These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 15915536)

  • 41. Involvement of secretory and endosomal compartments in presentation of an exogenous self-glycolipid to type II NKT cells.
    Roy KC; Maricic I; Khurana A; Smith TR; Halder RC; Kumar V
    J Immunol; 2008 Mar; 180(5):2942-50. PubMed ID: 18292516
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Viral danger signals control CD1d de novo synthesis and NKT cell activation.
    Raftery MJ; Winau F; Giese T; Kaufmann SH; Schaible UE; Schönrich G
    Eur J Immunol; 2008 Mar; 38(3):668-79. PubMed ID: 18253929
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cutting edge: influence of the TCR V beta domain on the avidity of CD1d:alpha-galactosylceramide binding by invariant V alpha 14 NKT cells.
    Schümann J; Voyle RB; Wei BY; MacDonald HR
    J Immunol; 2003 Jun; 170(12):5815-9. PubMed ID: 12794105
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CD1d is expressed on B-chronic lymphocytic leukemia cells and mediates alpha-galactosylceramide presentation to natural killer T lymphocytes.
    Fais F; Morabito F; Stelitano C; Callea V; Zanardi S; Scudeletti M; Varese P; Ciccone E; Grossi CE
    Int J Cancer; 2004 Apr; 109(3):402-11. PubMed ID: 14961579
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Liposomal glycosphingolipids activate natural killer T cell-mediated immune responses through the endosomal pathway.
    Inoue J; Ideue R; Takahashi D; Kubota M; Kumazawa Y
    J Control Release; 2009 Jan; 133(1):18-23. PubMed ID: 18930085
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cutting edge: impaired glycosphingolipid trafficking and NKT cell development in mice lacking Niemann-Pick type C1 protein.
    Sagiv Y; Hudspeth K; Mattner J; Schrantz N; Stern RK; Zhou D; Savage PB; Teyton L; Bendelac A
    J Immunol; 2006 Jul; 177(1):26-30. PubMed ID: 16785493
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Saposins facilitate CD1d-restricted presentation of an exogenous lipid antigen to T cells.
    Kang SJ; Cresswell P
    Nat Immunol; 2004 Feb; 5(2):175-81. PubMed ID: 14716312
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A molecular switch in mouse CD1d modulates natural killer T cell activation by α-galactosylsphingamides.
    Wang J; Guillaume J; Janssens J; Remesh SG; Ying G; Bitra A; Van Calenbergh S; Zajonc DM
    J Biol Chem; 2019 Sep; 294(39):14345-14356. PubMed ID: 31391251
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glycosylphosphatidylinositol-anchored mucin-like glycoproteins from Trypanosoma cruzi bind to CD1d but do not elicit dominant innate or adaptive immune responses via the CD1d/NKT cell pathway.
    Procópio DO; Almeida IC; Torrecilhas AC; Cardoso JE; Teyton L; Travassos LR; Bendelac A; Gazzinelli RT
    J Immunol; 2002 Oct; 169(7):3926-33. PubMed ID: 12244192
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Crucial amino acid residues of mouse CD1d for glycolipid ligand presentation to V(alpha)14 NKT cells.
    Kamada N; Iijima H; Kimura K; Harada M; Shimizu E; Motohashi Si ; Kawano T; Shinkai H; Nakayama T; Sakai T; Brossay L; Kronenberg M; Taniguchi M
    Int Immunol; 2001 Jul; 13(7):853-61. PubMed ID: 11431415
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria.
    Kinjo Y; Tupin E; Wu D; Fujio M; Garcia-Navarro R; Benhnia MR; Zajonc DM; Ben-Menachem G; Ainge GD; Painter GF; Khurana A; Hoebe K; Behar SM; Beutler B; Wilson IA; Tsuji M; Sellati TJ; Wong CH; Kronenberg M
    Nat Immunol; 2006 Sep; 7(9):978-86. PubMed ID: 16921381
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A novel recognition motif of human NKT antigen receptor for a glycolipid ligand.
    Kawano T; Tanaka Y; Shimizu E; Kaneko Y; Kamata N; Sato H; Osada H; Sekiya S; Nakayama T; Taniguchi M
    Int Immunol; 1999 Jun; 11(6):881-7. PubMed ID: 10360961
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CD1d-expressing dendritic cells but not thymic epithelial cells can mediate negative selection of NKT cells.
    Chun T; Page MJ; Gapin L; Matsuda JL; Xu H; Nguyen H; Kang HS; Stanic AK; Joyce S; Koltun WA; Chorney MJ; Kronenberg M; Wang CR
    J Exp Med; 2003 Apr; 197(7):907-18. PubMed ID: 12682110
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Production and characterization of monoclonal antibodies against complexes of the NKT cell ligand alpha-galactosylceramide bound to mouse CD1d.
    Yu KO; Im JS; Illarionov PA; Ndonye RM; Howell AR; Besra GS; Porcelli SA
    J Immunol Methods; 2007 May; 323(1):11-23. PubMed ID: 17442335
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Niemann-Pick type C2 protein loads isoglobotrihexosylceramide onto CD1d molecules and contributes to the thymic selection of NKT cells.
    Schrantz N; Sagiv Y; Liu Y; Savage PB; Bendelac A; Teyton L
    J Exp Med; 2007 Apr; 204(4):841-52. PubMed ID: 17389239
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impaired selection of invariant natural killer T cells in diverse mouse models of glycosphingolipid lysosomal storage diseases.
    Gadola SD; Silk JD; Jeans A; Illarionov PA; Salio M; Besra GS; Dwek R; Butters TD; Platt FM; Cerundolo V
    J Exp Med; 2006 Oct; 203(10):2293-303. PubMed ID: 16982810
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mechanisms imposing the Vbeta bias of Valpha14 natural killer T cells and consequences for microbial glycolipid recognition.
    Wei DG; Curran SA; Savage PB; Teyton L; Bendelac A
    J Exp Med; 2006 May; 203(5):1197-207. PubMed ID: 16651387
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CD1d-dependent activation of NKT cells aggravates atherosclerosis.
    Tupin E; Nicoletti A; Elhage R; Rudling M; Ljunggren HG; Hansson GK; Berne GP
    J Exp Med; 2004 Feb; 199(3):417-22. PubMed ID: 14744994
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Both CD1d antigen presentation and interleukin-12 are required to activate natural killer T cells during Trypanosoma cruzi infection.
    Duthie MS; Kahn M; White M; Kapur RP; Kahn SJ
    Infect Immun; 2005 Mar; 73(3):1890-4. PubMed ID: 15731095
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Scavenger receptors target glycolipids for natural killer T cell activation.
    Freigang S; Landais E; Zadorozhny V; Kain L; Yoshida K; Liu Y; Deng S; Palinski W; Savage PB; Bendelac A; Teyton L
    J Clin Invest; 2012 Nov; 122(11):3943-54. PubMed ID: 23064364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.